1 전혜영, "Warfarin에 의한 과도한 항응고 효과의 치료현황 평가" 한국병원약사회 26 (26): 66-77, 2009
2 DeZee K. D., "Treatment of excessive anticoagulation with phytonadione (vitamin K)" 166 : 391-397, 2006
3 Dentali F., "Treatment of coumarin-associated coagulopathy:a systematic review and proposed treatment algorithms" 4 : 1853-1863, 2006
4 Demirkan K., "Response to warfarin and other oral anticoagulants: effects of disease states" 93 (93): 448-454, 2000
5 Patel R. J., "Randomized, placebocontrolled trial of oral phytonadione for excessive anticoagulation" 20 (20): 1159-1166, 2000
6 Ansell J., "Pharmacology and Management of the vitamin K antagonist, American College of Chest Practice Guidelines" 133 : 160-198, 2008
7 Crowther M.A., "Oral vitamin K Versus Placebo to Correct Excessive Anticoagulation In Patients Receiving Warfarin" 150 : 293-300, 2009
8 Hirsh J., "Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range" 119 : 8S-21S, 2001
9 "International Society on Thrombosis and Haemostasis, Inc."
10 Rose A. J., "Epidemiology of subtherapeutic anticoagulation in the United States" 2 : 591-597, 2009
1 전혜영, "Warfarin에 의한 과도한 항응고 효과의 치료현황 평가" 한국병원약사회 26 (26): 66-77, 2009
2 DeZee K. D., "Treatment of excessive anticoagulation with phytonadione (vitamin K)" 166 : 391-397, 2006
3 Dentali F., "Treatment of coumarin-associated coagulopathy:a systematic review and proposed treatment algorithms" 4 : 1853-1863, 2006
4 Demirkan K., "Response to warfarin and other oral anticoagulants: effects of disease states" 93 (93): 448-454, 2000
5 Patel R. J., "Randomized, placebocontrolled trial of oral phytonadione for excessive anticoagulation" 20 (20): 1159-1166, 2000
6 Ansell J., "Pharmacology and Management of the vitamin K antagonist, American College of Chest Practice Guidelines" 133 : 160-198, 2008
7 Crowther M.A., "Oral vitamin K Versus Placebo to Correct Excessive Anticoagulation In Patients Receiving Warfarin" 150 : 293-300, 2009
8 Hirsh J., "Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range" 119 : 8S-21S, 2001
9 "International Society on Thrombosis and Haemostasis, Inc."
10 Rose A. J., "Epidemiology of subtherapeutic anticoagulation in the United States" 2 : 591-597, 2009
11 Denas G., "Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K : a retrospective study of 1043 cases" 27 : 340-347, 2009
12 Palareti G., "Bleeding complications of oral anticoagulant treatment : an inception-cohort, prospective collaborative study(ISCOAT)" 348 : 423-428, 1996
13 Holbrook A., "Antithrombotic therapy and prevention of thrombosis, American College of Chest, Physicians Evidence-Based Clinical Practice Guidelines" 141 (141): e152s-e184s, 2012
14 Fiore LD, "Anaphylactoid reactions to vitamin" 11 : 175-183, 2001
15 "American Hospital Formulary Service (AHFS)"
16 Watson H. G., "A comparison of the efficacy and rate of response to oral and intravenous vitamin K in reversal of overanticoagulation with warfarin" 115 : 145-149, 2001